|
Re: Short interest
|
3
|
Resverlogix Corp.
|
Apr 02, 2021 03:31PM
|
|
Extracorporeal membrane oxygenation
|
2
|
Resverlogix Corp.
|
Apr 01, 2021 09:23AM
|
|
Re: Year-end financials
|
3
|
Resverlogix Corp.
|
Apr 01, 2021 08:18AM
|
|
BTI press release March 31, 2021 16:05 ET
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2021 04:14PM
|
|
Re: Biotech Valuation
|
6
|
Resverlogix Corp.
|
Mar 31, 2021 07:06AM
|
|
Re: Where do we go from here?
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2021 10:41AM
|
|
Re: Where do we go from here?
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2021 09:31AM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 04:57PM
|
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 07:10AM
|
|
Re: Compensation Commity
|
3
|
Resverlogix Corp.
|
Mar 28, 2021 02:17PM
|
|
Re: Warning: Long - Thoughts on Management
|
1
|
Resverlogix Corp.
|
Mar 25, 2021 11:35AM
|
|
Re: Exempt
|
3
|
Resverlogix Corp.
|
Mar 24, 2021 05:58PM
|
|
Re: Exempt
|
2
|
Resverlogix Corp.
|
Mar 24, 2021 04:03PM
|
|
Exempt Distribution- 2021-03-23
|
3
|
Resverlogix Corp.
|
Mar 24, 2021 02:46PM
|
|
Re: Why have we not heard more about CURATE-AI?
|
2
|
Zenith Epigenetics
|
Mar 24, 2021 10:50AM
|
|
Re: Why have we not heard more about CURATE-AI?
|
2
|
Zenith Epigenetics
|
Mar 24, 2021 09:45AM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 23, 2021 05:33AM
|
|
Warrant Extension and Repricing
|
2
|
Resverlogix Corp.
|
Mar 22, 2021 07:19PM
|
|
Warrant Extension and Repricing
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 22, 2021 07:15PM
|
|
Re: We should get financials this week
|
1
|
Resverlogix Corp.
|
Mar 22, 2021 06:36PM
|
